Market Overview:
The global esomeprazole sodium market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of gastrointestinal disorders, rising geriatric population, and growing demand for generic drugs. By type, the purity above 99% segment is expected to grow at a higher CAGR than the purity:99% segment during the forecast period. By application, stomach ulcers treatment is expected to hold the largest share of the global esomeprazole sodium market in 2018. However, zollinger-ellison syndrome treatment is projected to grow at a higher CAGR than stomach ulcers treatment during the forecast period.
Product Definition:
Esomeprazole Sodium is a proton pump inhibitor which is used in the treatment of gastroesophageal reflux disease, erosive esophagitis, and Zollinger-Ellison syndrome.
Purity:99%:
Purity:99% is a new term in the pharmaceutical industry. It means that 99% of the substance being tested or manufactured is present in said quantity and quality as stated on the label. For example, if a medicine has been tested to contain 100 mg of actual drug substance, then it means that every milligram of drug substance should be present in every dose of final product without any kind of contamination.
Purity:Above 99%:
The purity of the product is very important for pharmaceuticals. It plays a vital role in determining the quality, strength, and safety of products manufactured. The impurities present can have an adverse effect on the patients during treatment which may lead to fatalities. Hence strict regulations are there to ensure that no contaminants enter into the final product.
Application Insights:
Stomach ulcers treatment was the largest application segment in 2017. The product is used for the treatment of duodenal and gastric ulcers. It is also effective in treating perforating ulcers, which require surgical intervention to heal. However, esomeprazole sodium is not suitable for use in patients who have a history of allergic reaction to it or are sensitive to aspirin due Ulcerative colitis disease (UC) as well as Crohn¢â‚¬â„¢s disease (CD).
The others segment includes conditions such as heartburn, burning sensation in the chest, nausea and vomiting. Esomeprazole sodium reduces these symptoms by inhibiting histamine release from basophils and mast cells thus providing relief from these conditions.
Regional Analysis:
Europe dominated the global esomeprazole sodium market in terms of revenue with a share of over 40.0% in 2017. This is attributed to the high prevalence of diseases such as gastric ulcers and zollinger-ellison syndrome (ZES) in this region, which mandates the use of proton pump inhibitors for treatment. Moreover, new product launches by major players are anticipated to further boost demand for ESPOROS during the forecast period.
Asia Pacific is expected to witness significant growth over the forecast period owing to rising geriatric population and awareness about drug therapies among patients suffering from acid reflux disease or stomach ulcers conditions coupled with increasing disposable income levels especially in developing countries such as China & India will drive regional growth during future years.
Growth Factors:
- Increasing prevalence of gastrointestinal diseases: The increasing prevalence of gastrointestinal diseases is one of the major growth drivers for the Esomeprazole Sodium market. Esomeprazole Sodium is used for the treatment of various gastrointestinal diseases such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger-Ellison syndrome. This will lead to an increase in demand for Esomeprazole Sodium products, thereby driving the market growth.
- Rising geriatric population: The geriatric population is at a higher risk of developing various gastrointestinal disorders such as GERD, peptic ulcer disease, and gastric cancer. This will lead to an increase in demand for Esomeprazole Sodium products among this population segment, thereby propelling market growth.
- Growing awareness about acid reflux and its treatment options: There has been a growing awareness about acid reflux and its treatment options among consumers in recent years. This has led to an increase in demand for Esomeprazole Sodium products as they are effective treatments for acid reflux disorders. This will help drive market growth during the forecast period..
Scope Of The Report
Report Attributes
Report Details
Report Title
Esomeprazole Sodium Market Research Report
By Type
Purity:99%, Purity:Above 99%
By Application
Stomach Ulcers Treatment, Zollinger-ellison Syndrome Treatment, Others
By Companies
EsteveQuÃmica, Everest Organics, Jubilant Pharma, Cemex Pharma, Anuja Healthcare, Zhejiang Davi Pharmaceutial, Rajasthan Antibiotics, Sainor Life Sciences, EsteveQuÃmica
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
147
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Esomeprazole Sodium Market Report Segments:
The global Esomeprazole Sodium market is segmented on the basis of:
Types
Purity:99%, Purity:Above 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Stomach Ulcers Treatment, Zollinger-ellison Syndrome Treatment, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- EsteveQuÃmica
- Everest Organics
- Jubilant Pharma
- Cemex Pharma
- Anuja Healthcare
- Zhejiang Davi Pharmaceutial
- Rajasthan Antibiotics
- Sainor Life Sciences
- EsteveQuÃmica
Highlights of The Esomeprazole Sodium Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity:99%
- Purity:Above 99%
- By Application:
- Stomach Ulcers Treatment
- Zollinger-ellison Syndrome Treatment
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Esomeprazole Sodium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Esomeprazole Sodium is a medication used to treat gastroesophageal reflux disease (GERD). Esomeprazole helps to reduce the amount of acid that flows back up the esophagus. It is also used to prevent heartburn and other symptoms of GERD. Esomeprazole may be prescribed as a single dose or in combination with other medications.
Some of the major companies in the esomeprazole sodium market are EsteveQuƒÂmica, Everest Organics, Jubilant Pharma, Cemex Pharma, Anuja Healthcare, Zhejiang Davi Pharmaceutial, Rajasthan Antibiotics, Sainor Life Sciences, EsteveQuƒÂmica.
The esomeprazole sodium market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Esomeprazole Sodium Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Esomeprazole Sodium Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Esomeprazole Sodium Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Esomeprazole Sodium Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Esomeprazole Sodium Market Size & Forecast, 2018-2028 4.5.1 Esomeprazole Sodium Market Size and Y-o-Y Growth 4.5.2 Esomeprazole Sodium Market Absolute $ Opportunity
Chapter 5 Global Esomeprazole Sodium Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Esomeprazole Sodium Market Size Forecast by Type
5.2.1 Purity:99%
5.2.2 Purity:Above 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Esomeprazole Sodium Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Esomeprazole Sodium Market Size Forecast by Applications
6.2.1 Stomach Ulcers Treatment
6.2.2 Zollinger-ellison Syndrome Treatment
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Esomeprazole Sodium Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Esomeprazole Sodium Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Esomeprazole Sodium Analysis and Forecast
9.1 Introduction
9.2 North America Esomeprazole Sodium Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Esomeprazole Sodium Market Size Forecast by Type
9.6.1 Purity:99%
9.6.2 Purity:Above 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Esomeprazole Sodium Market Size Forecast by Applications
9.10.1 Stomach Ulcers Treatment
9.10.2 Zollinger-ellison Syndrome Treatment
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Esomeprazole Sodium Analysis and Forecast
10.1 Introduction
10.2 Europe Esomeprazole Sodium Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Esomeprazole Sodium Market Size Forecast by Type
10.6.1 Purity:99%
10.6.2 Purity:Above 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Esomeprazole Sodium Market Size Forecast by Applications
10.10.1 Stomach Ulcers Treatment
10.10.2 Zollinger-ellison Syndrome Treatment
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Esomeprazole Sodium Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Esomeprazole Sodium Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Esomeprazole Sodium Market Size Forecast by Type
11.6.1 Purity:99%
11.6.2 Purity:Above 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Esomeprazole Sodium Market Size Forecast by Applications
11.10.1 Stomach Ulcers Treatment
11.10.2 Zollinger-ellison Syndrome Treatment
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Esomeprazole Sodium Analysis and Forecast
12.1 Introduction
12.2 Latin America Esomeprazole Sodium Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Esomeprazole Sodium Market Size Forecast by Type
12.6.1 Purity:99%
12.6.2 Purity:Above 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Esomeprazole Sodium Market Size Forecast by Applications
12.10.1 Stomach Ulcers Treatment
12.10.2 Zollinger-ellison Syndrome Treatment
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Esomeprazole Sodium Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Esomeprazole Sodium Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Esomeprazole Sodium Market Size Forecast by Type
13.6.1 Purity:99%
13.6.2 Purity:Above 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Esomeprazole Sodium Market Size Forecast by Applications
13.10.1 Stomach Ulcers Treatment
13.10.2 Zollinger-ellison Syndrome Treatment
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Esomeprazole Sodium Market: Competitive Dashboard
14.2 Global Esomeprazole Sodium Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 EsteveQuÃmica
14.3.2 Everest Organics
14.3.3 Jubilant Pharma
14.3.4 Cemex Pharma
14.3.5 Anuja Healthcare
14.3.6 Zhejiang Davi Pharmaceutial
14.3.7 Rajasthan Antibiotics
14.3.8 Sainor Life Sciences
14.3.9 EsteveQuÃmica